ID

25777

Description

Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT00446966

Link

https://clinicaltrials.gov/show/NCT00446966

Keywords

Versions (1)
  1. 9/19/17 9/19/17 -
Uploaded on

September 19, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Atrial Fibrillation NCT00446966

English

Eligibility Atrial Fibrillation NCT00446966

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18-85 years old.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
elective coronary cabg operation with or without concomitant valve surgery planned for at least 2 days after enrollment.
Description

Coronary Artery Bypass Surgery elective | Heart Valve Operative Surgical Procedures Planned

Data type

boolean

Alias
UMLS CUI [1,1]
C0010055
UMLS CUI [1,2]
C0439608
UMLS CUI [2,1]
C0018826
UMLS CUI [2,2]
C0543467
UMLS CUI [2,3]
C1301732
signed, documented informed consent prior to admission to the study.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
urgent or emergent bypass required to be performed <24 hrs after screening.
Description

Bypass Urgent Patient need for | Bypass Emergency Patient need for

Data type

boolean

Alias
UMLS CUI [1,1]
C0741847
UMLS CUI [1,2]
C0439609
UMLS CUI [1,3]
C0686904
UMLS CUI [2,1]
C0741847
UMLS CUI [2,2]
C0013956
UMLS CUI [2,3]
C0686904
unstable angina, requiring intervention or cabg <24 hrs after screening.
Description

Unstable Angina Requirement Intervention | Unstable Angina Requirement Coronary Artery Bypass Surgery

Data type

boolean

Alias
UMLS CUI [1,1]
C0002965
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0184661
UMLS CUI [2,1]
C0002965
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0010055
decompensated congestive heart failure.
Description

CONGESTIVE HEART FAILURE DECOMPENSATED

Data type

boolean

Alias
UMLS CUI [1]
C0742746
chronic, persistent atrial fibrillation - patient in atrial fibrillation at the time of screening or enrollment or scheduled for a maze procedure or pulmonary vein isolation at the time of surgery.
Description

Persistent atrial fibrillation chronic | Maze Procedure Scheduled | Pulmonary vein isolation Scheduled

Data type

boolean

Alias
UMLS CUI [1,1]
C2585653
UMLS CUI [1,2]
C0205191
UMLS CUI [2,1]
C3272262
UMLS CUI [2,2]
C0205539
UMLS CUI [3,1]
C3544330
UMLS CUI [3,2]
C0205539
known sensitivity to omacor (0mega-3 acid ethyl esters) and hypersensitivity to fish, fish products or corn oil.
Description

Hypersensitivity Lovaza | Hypersensitivity Omega-3 Acid Ethyl Esters | Allergy to fish | Hypersensitivity Fish Products | Hypersensitivity Corn Oil

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0912903
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1532673
UMLS CUI [3]
C0856904
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0016158
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0010029
patients requiring warfarin or lovenox the 2 days prior to bypass surgery.
Description

Warfarin Patient need for | Lovenox Patient need for

Data type

boolean

Alias
UMLS CUI [1,1]
C0043031
UMLS CUI [1,2]
C0686904
UMLS CUI [2,1]
C0728963
UMLS CUI [2,2]
C0686904
patients on class i or iii antiarrhythmic agents (quinidine, procainamide, disopyramide, flecainide, propafenone, moricizine, dofetilide, sotalol, amiodarone) or who have taken these drugs within 5 elimination half-lives of the drug (or within 2 months for amiodarone).
Description

Anti-Arrhythmia Agents Class | Quinidine | Procainamide | Disopyramide | Flecainide | Propafenone | Moricizine | dofetilide | Sotalol | Amiodarone

Data type

boolean

Alias
UMLS CUI [1,1]
C0003195
UMLS CUI [1,2]
C0456387
UMLS CUI [2]
C0034414
UMLS CUI [3]
C0033216
UMLS CUI [4]
C0012702
UMLS CUI [5]
C0016229
UMLS CUI [6]
C0033429
UMLS CUI [7]
C0079856
UMLS CUI [8]
C0114771
UMLS CUI [9]
C0037707
UMLS CUI [10]
C0002598
patients who are pregnant or nursing.
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients unable to provide/sign informed consent.
Description

Informed Consent Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
patients currently enrolled in another clinical trial without a 30 day washout period.
Description

Study Subject Participation Status | Washout Period Lacking

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C1710661
UMLS CUI [2,2]
C0332268
patients currently taking marine based omega-three fish oil supplements.
Description

Omega-3 Fish Oil Supplement Marine-based

Data type

boolean

Alias
UMLS CUI [1,1]
C0015689
UMLS CUI [1,2]
C0016157
UMLS CUI [1,3]
C2348609
UMLS CUI [1,4]
C3829196
Back to the top of the page

Similar models

Eligibility Atrial Fibrillation NCT00446966

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18-85 years old.
boolean
C0001779 (UMLS CUI [1])
Coronary Artery Bypass Surgery elective | Heart Valve Operative Surgical Procedures Planned
Item
elective coronary cabg operation with or without concomitant valve surgery planned for at least 2 days after enrollment.
boolean
C0010055 (UMLS CUI [1,1])
C0439608 (UMLS CUI [1,2])
C0018826 (UMLS CUI [2,1])
C0543467 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
Informed Consent
Item
signed, documented informed consent prior to admission to the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Bypass Urgent Patient need for | Bypass Emergency Patient need for
Item
urgent or emergent bypass required to be performed <24 hrs after screening.
boolean
C0741847 (UMLS CUI [1,1])
C0439609 (UMLS CUI [1,2])
C0686904 (UMLS CUI [1,3])
C0741847 (UMLS CUI [2,1])
C0013956 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])
Unstable Angina Requirement Intervention | Unstable Angina Requirement Coronary Artery Bypass Surgery
Item
unstable angina, requiring intervention or cabg <24 hrs after screening.
boolean
C0002965 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])
C0002965 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0010055 (UMLS CUI [2,3])
CONGESTIVE HEART FAILURE DECOMPENSATED
Item
decompensated congestive heart failure.
boolean
C0742746 (UMLS CUI [1])
Persistent atrial fibrillation chronic | Maze Procedure Scheduled | Pulmonary vein isolation Scheduled
Item
chronic, persistent atrial fibrillation - patient in atrial fibrillation at the time of screening or enrollment or scheduled for a maze procedure or pulmonary vein isolation at the time of surgery.
boolean
C2585653 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C3272262 (UMLS CUI [2,1])
C0205539 (UMLS CUI [2,2])
C3544330 (UMLS CUI [3,1])
C0205539 (UMLS CUI [3,2])
Hypersensitivity Lovaza | Hypersensitivity Omega-3 Acid Ethyl Esters | Allergy to fish | Hypersensitivity Fish Products | Hypersensitivity Corn Oil
Item
known sensitivity to omacor (0mega-3 acid ethyl esters) and hypersensitivity to fish, fish products or corn oil.
boolean
C0020517 (UMLS CUI [1,1])
C0912903 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1532673 (UMLS CUI [2,2])
C0856904 (UMLS CUI [3])
C0020517 (UMLS CUI [4,1])
C0016158 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0010029 (UMLS CUI [5,2])
Warfarin Patient need for | Lovenox Patient need for
Item
patients requiring warfarin or lovenox the 2 days prior to bypass surgery.
boolean
C0043031 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0728963 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
Anti-Arrhythmia Agents Class | Quinidine | Procainamide | Disopyramide | Flecainide | Propafenone | Moricizine | dofetilide | Sotalol | Amiodarone
Item
patients on class i or iii antiarrhythmic agents (quinidine, procainamide, disopyramide, flecainide, propafenone, moricizine, dofetilide, sotalol, amiodarone) or who have taken these drugs within 5 elimination half-lives of the drug (or within 2 months for amiodarone).
boolean
C0003195 (UMLS CUI [1,1])
C0456387 (UMLS CUI [1,2])
C0034414 (UMLS CUI [2])
C0033216 (UMLS CUI [3])
C0012702 (UMLS CUI [4])
C0016229 (UMLS CUI [5])
C0033429 (UMLS CUI [6])
C0079856 (UMLS CUI [7])
C0114771 (UMLS CUI [8])
C0037707 (UMLS CUI [9])
C0002598 (UMLS CUI [10])
Pregnancy | Breast Feeding
Item
patients who are pregnant or nursing.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Informed Consent Unable
Item
patients unable to provide/sign informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Study Subject Participation Status | Washout Period Lacking
Item
patients currently enrolled in another clinical trial without a 30 day washout period.
boolean
C2348568 (UMLS CUI [1])
C1710661 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Omega-3 Fish Oil Supplement Marine-based
Item
patients currently taking marine based omega-three fish oil supplements.
boolean
C0015689 (UMLS CUI [1,1])
C0016157 (UMLS CUI [1,2])
C2348609 (UMLS CUI [1,3])
C3829196 (UMLS CUI [1,4])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial